Acute pancreatitis during pegylated interferon therapy in a patient with chronic hepatitis B.
Vignon
Rodolph K
RK
Seddik
Hassan
H
Rouibaa
Fedoua
F
En-Nouali
Hassane
H
Kabbaj
Nawal
N
Benkirane
Ahmed
A
D000208:Acute Disease; D000998:Antiviral Agents / Q000009:adverse effects*; D016903:Drug Monitoring; D042241:Early Diagnosis; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced* / Q000175:diagnosis; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a